glp-1 alcohol abuse Medscape | Once weekly semaglutide injections reduced consumption in patients with alcohol use disorder and comorbid obesity. Results of the Popular Weight-Loss Drugs May Also

The FDA has acknowledged this reality on the label itself: weight care requires ongoing therapy , and GLP-1 drugs are approved for chronic weight management only as an adjunct to diet and exercise they are not magic bullets that cure obesity after a few doses

Swimming, cycling, brisk walking, light jogging, or even dancing all qualify

it affects electrolyte transport across the intestinal mucosa and enhances colonic transport and motility

Some healthcare providers may prescribe both off-label in select cases, but this requires careful patient selection, comprehensive cardiovascular screening, and close monitoring for additive side effects including increased heart rate, blood pressure changes, and gastrointestinal symptoms

Larry Hornsby, chairman of the board for WCP added, At Wellstar, we all work together to keep our communities healthy